Preventive strategies to lower hand-foot syndrome risk

Diclofenac gel and the topical flavonoid silymarin, or milk thistle, may be effective in preventing chemotherapy-induced hand-foot syndrome, according to a study published in JAMA Dermatology.
Hand-foot syndrome is a cutaneous adverse event of chemotherapy, characterized by tingling, numbness, desquamation, blistering and/or ulceration of the palms and soles. A dose-dependent toxic effect, hand-foot syndrome is associated with several chemotherapy drugs including 5-fluorouracil, capecitabine, liposomal doxorubicin, cytarabine and docetaxel, according to the researchers.
Capecitabine (Xeloda,






